Track topics on Twitter Track topics that are important to you
Pathogen infections are among the leading causes for disease and mortality throughout the globe. As more pathogenic strains develop resistance to existing drugs, the race for finding novel anti-bacterial and anti-fungal drugs becomes ever more urgent. The field of pathogenomics utilizes data acquired by genomics and related methods in order to better characterize pathogenic bacteria and fungi, interactions between different strains, and interactions between the pathogen and the human host. Pathogenomics has already been invaluable in understanding pathogenic evolution and diversity, in characterizing novel virulence factors, and in paving the way towards designing new diagnostic tests and drugs that will help keep humankind abreast of ever-changing pathogens.
IslandViewer (http://www.pathogenomics.sfu.ca/islandviewer/) is a widely-used webserver for the prediction and interactive visualization of genomic islands (GIs, regions of probable horizontal origin)...
Clostridium tetani and Clostridium botulinum produce two of the most potent neurotoxins known, tetanus neurotoxin and botulinum neurotoxin, respectively. Extensive biochemical and genetic investigatio...
Pathogen infections are among the leading causes for disease and mortality throughout the globe. As more pathogenic strains develop resistance to existing drugs, the race for find...
Infect-ERA, a consortium funded under the Seventh Framework programme (FP7), is a continuation of the former ERA-NET PathoGenoMics. To date, it includes 14 partners from 11...
We have published hundreds of ERA-NET PathoGenoMics news stories on BioPortfolio along with dozens of ERA-NET PathoGenoMics Clinical Trials and PubMed Articles about ERA-NET PathoGenoMics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERA-NET PathoGenoMics Companies in our database. You can also find out about relevant ERA-NET PathoGenoMics Drugs and Medications on this site too.